Short reply to "Proton therapy for newly diagnosed glioblastoma: more room for investigation" by R. Press et al.
作者信息
Chung Caroline, Brown Paul D, Wefel Jeffrey S
机构信息
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Neuro Oncol. 2021 Nov 2;23(11):1982. doi: 10.1093/neuonc/noab193.
Abstract
摘要
相似文献
1
Short reply to "Proton therapy for newly diagnosed glioblastoma: more room for investigation" by R. Press et al.对R. Press等人所著《新诊断胶质母细胞瘤的质子治疗：仍有更多研究空间》的简短回应
Neuro Oncol. 2021 Nov 2;23(11):1982. doi: 10.1093/neuonc/noab193.
2
Proton therapy for newly diagnosed glioblastoma: more room for investigation.新诊断胶质母细胞瘤的质子治疗：仍有更多研究空间。
Neuro Oncol. 2021 Nov 2;23(11):1980-1981. doi: 10.1093/neuonc/noab139.
3
Can proton therapy reduce radiation-related lymphopenia in glioblastoma?质子治疗能减少胶质母细胞瘤中与放疗相关的淋巴细胞减少吗？
Neuro Oncol. 2021 Feb 25;23(2):179-181. doi: 10.1093/neuonc/noaa273.
4
In reply to Sharma et al.
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):631-2. doi: 10.1016/j.ijrobp.2013.07.027.
5
Photon vs. proton radiochemotherapy: Effects on brain tissue volume and perfusion.光子与质子放化疗对脑组织体积和灌注的影响。
Radiother Oncol. 2018 Jul;128(1):121-127. doi: 10.1016/j.radonc.2017.11.033. Epub 2018 Jan 19.
6
In Reply to Levra et al.
Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):218-9. doi: 10.1016/j.ijrobp.2015.05.007.
7
Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy.多形性胶质母细胞瘤采用超分割同步加量质子束治疗后的长期生存情况。
Pract Radiat Oncol. 2015 Jan-Feb;5(1):e9-16. doi: 10.1016/j.prro.2014.03.012. Epub 2014 May 19.
8
Radiation as a foundation for glioblastoma therapy in elderly patients. In Regard to Arvold et al.放射治疗作为老年胶质母细胞瘤患者治疗的基础。关于阿诺德等人的研究。
Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):217-8. doi: 10.1016/j.ijrobp.2015.05.006.
9
Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis. In regard to Lee et al.胶质母细胞瘤中同侧脑室下区高剂量放射治疗的评估：一项汇总分析。关于Lee等人的研究。
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):631. doi: 10.1016/j.ijrobp.2013.07.026.
10
Tumor Control in RG2 Glioma-Bearing Rats: A Comparison Between Proton Minibeam Therapy and Standard Proton Therapy.RG2 神经胶质瘤荷瘤鼠的肿瘤控制：质子微射束治疗与标准质子治疗的比较。
Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):266-271. doi: 10.1016/j.ijrobp.2019.01.080. Epub 2019 Jan 29.
本文引用的文献
1
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.一项质子放疗与调强放疗治疗新诊断胶质母细胞瘤患者的前瞻性 II 期随机试验。
Neuro Oncol. 2021 Aug 2;23(8):1337-1347. doi: 10.1093/neuonc/noab040.
2
Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis.新诊断的胶质母细胞瘤经放化疗后行海马保护 VMAT 的可行性：失败模式分析。
Radiat Oncol. 2020 May 6;15(1):98. doi: 10.1186/s13014-020-01552-0.
3
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.全脑放疗联合美金刚治疗脑转移瘤患者时对海马的回避：NRG 肿瘤学 CC001 期临床试验。
J Clin Oncol. 2020 Apr 1;38(10):1019-1029. doi: 10.1200/JCO.19.02767. Epub 2020 Feb 14.
4
Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma.质子治疗相对于传统光子放疗在年轻患者和低级别胶质瘤成年患者中的剂量学优势。
Strahlenther Onkol. 2016 Nov;192(11):759-769. doi: 10.1007/s00066-016-1005-9. Epub 2016 Jun 30.
Zotero 插件